EAM INVESTORS, LLC – Revance Therapeutics, Inc. Transaction History
EAM INVESTORS, LLC portfolio value:
$2.54M
portfolio value
Revance Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 94.41K shares | 2.54M | $27 | 94.41K |
Q4 2020 | share | Decrease | -100.00% | -42.53K shares | -1.06M | $28.34 | 0 |
Q3 2020 | share | Increase | +34.82% | 10.98K shares | 299K | $25.14 | 42.53K |
Q2 2020 | share | Decrease | -63.01% | -53.75K shares | -492K | $24.42 | 31.55K |
Q1 2020 | share | Decrease | -19.09% | -20.12K shares | -449K | $14.8 | 85.30K |
Q4 2019 | share | Increase | 0.00% | 105.42K shares | 1.71M | $16.23 | 105.42K |
Q2 2018 | share | Decrease | -100.00% | -113.09K shares | -3.48M | $27.45 | 0 |
Q1 2018 | share | Increase | +5.37% | 5.76K shares | -354K | $30.8 | 113.09K |
Q4 2017 | share | Increase | +48.01% | 34.81K shares | 1.83M | $35.75 | 107.33K |
Q3 2017 | share | Increase | +113.94% | 38.62K shares | 1.10M | $27.55 | 72.51K |
Q2 2017 | share | Increase | 0.00% | 33.89K shares | 895K | $26.4 | 33.89K |
Q1 2016 | share | Decrease | -100.00% | -102.8K shares | -3.51M | $17.46 | 0 |